Welcome to Medications.com

Evaluate Therapies under Development for Peripheral Artery Disease ... - Business Wire (press release)

Cilostazol (Pletal), an antiplatelet, is recommended as first-line therapy for claudication The new agents in development for PAD are primarily as secondary ...

Posted: Wed Feb 06 04:58:59 -0500 2008




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea